< Back to latest news & events

Articles

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

February 2025

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed patent ban for NGT plants, plant material and plant products.

By way of reminder, in preparing legislation to relax the regulatory process for the marketing of NGT plants, the EU Parliament proposed an amendment which effectively excluded from patentability “NGT plants, parts thereof, genetic information, and the process features they contain”.  The proposal also included restrictions on the scope of protection of existing patents and applications for all NGT plants.  The purpose of the proposed ban was to avoid legal uncertainties, increased costs and dependencies on large agritech companies for farmers and breeders.  This, they argued, was in line with the EU Commission aim to develop sustainable agriculture and increase food security in the region.

Since the proposed amendment, there has been debate over the scope of the exclusion, which could have been interpreted as extending to the genetic tools used for targeted mutagenesis.  There has also been understandable reluctance in having to revise existing legislation such as the EU Biotech Directive, the UPCA and the Trips agreement, as well as questions over the amendments that might be needed to the European Patent Convention.  Despite softening the proposal to be limited to the lower-risk NGT1 plants only by the Belgian Presidency, they were unable to secure a majority vote.

The current Polish presidency have recognised that in order to implement the regulatory legislation, the deadlock between the EU member states on the proposed patent ban has to be promptly addressed.  With the objective of stimulating innovation in the EU whilst enabling free access to varieties by breeders, the Polish Presidency have proposed the following:

  • There will be a distinction between patents which protect basic technologies and patents for plants and processes which result in a specific plant trait.
  • Reproductive material of an NGT1 plant can be placed on the market without any further restrictions, if it is not protected by a product patent, or a process patent which results in a specific trait of the plant.
  • If there are patents which protect the reproductive material, or which protect a process which results in a specific trait, then the reproductive material can still be put on the market, but it may be subject to further restrictions if a Member State wishes. Such restrictions include: a ban on use of the reproductive material for cultivation of reproductive material and a labelling requirement.  These restrictions would aim to protect national farmers and breeders against patents.
  • The proposal includes a verification procedure to determine the existence of patents or applications which may be relevant, and this burden will fall to the party putting the reproductive material on the market.

It is notable that the provisions don’t relate to plants per se, or plant products but only to reproductive material.  The requirements are also limited to NGT1 plants, and any other reproductive material will not be subject to the verification procedure.

Many have welcomed the removal of the proposed patent ban, and if the Polish proposal is accepted then the legislation may progress forward, although there are still many non-IP related issues to resolve.


This article was prepared by Partners Punita Shah and Ellie Purnell.

Latest updates

Event - 24th June 2026

IP Clinic for SMEs at ETZ EnergyWorks

Following the success of our first session, we’re pleased to announce our next Intellectual Property (IP) clinic taking place at ETZ EnergyWorks in Aberdeen on Wednesday 24 June 2026, from …

Event details
Event - 2nd June 2026

HGF are proud sponsors of Retail Week General Counsel 2026

HGF is proud to be sponsoring Retail Week General Counsel. This will take place on Wednesday 3rd June at Ham Yard Hotel. The retail legal landscape is undergoing a fundamental …

Event details
Event - 5th May 2026

IP Clinic for SMEs at ETZ EnergyWorks

We’re pleased to announce a free Intellectual Property (IP) clinic taking place at ETZ EnergyWorks in Aberdeen on Wednesday 27th May, from 11.00am to 4.00pm, designed to support SMEs in …

Event details
Event - 11th - 12th May 2026

HGF is proud to be attending the 14th Microbiome R&D and Business Collaboration Forum: Europe 8th Skin Microbiome and Cosmeceuticals Congress: Europe.

HGF is proud to be attending the 14th Microbiome R&D and Business Collaboration Forum: Europe 8th Skin Microbiome and Cosmeceuticals Congress: Europe. It will be held on Monday 11-12th May …

Event details
Event - 27th April 2026

HGF are proud to be Gold Sponsors of IP Counsel Café

HGF are proud to be Gold Sponsors of IP Counsel Café on 12-14th May at Silicon Valley, US. HGF Partner Susan Keston will be speaking at on the topic AI …

Event details
Event - 16th April 2026

MedTech Innovation Summit 2026

HGF Partner and Patent Attorney Adam Hines will be attending the MedTech Innovation Summit Dublin 2026, taking place from 28–30 April at The Shelbourne Hotel. As one of Europe’s premier …

Event details
Event - 2nd - 6th May 2026

INTA 2026 Annual Meeting

HGF’s European team are delighted to be attending the INTA Annual Meeting 2026, taking place from 2nd-6th May in London. As one of Europe’s leading IP firms, HGF brings together …

Event details
Event - 25th March 2026

HGF Women IP Inclusive Event

HGF are hosting Connected Bubbles Networking Event on Wednesday 25 March 2026 and this year they are teaming up with CIPA! In a profession built on collaboration, referrals and trusted …

Event details